Original Articles
Copyright ©The Author(s) 1999.
World J Gastroenterol. Apr 15, 1999; 5(2): 152-155
Published online Apr 15, 1999. doi: 10.3748/wjg.v5.i2.152
Figure 1
Figure 1 Survival curves for patients with early can cer with C-erbB-2 amplification (n = 4) and for those with no C-erbB-2 amp lification (n = 24, P < 0. 05).
Figure 2
Figure 2 Survival curves for patients with well-moderately carcinoma with C-erbB-2 amplification (n = 17) and for those with no C-erbB-2 amplification (n = 28, P < 0. 05).